Randomized Prospective Comparison of Everolimus-Eluting vs. Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention　― 3-Year Clinical Outcomes of the EXCELLENT Randomized Trial ―-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Randomized Prospective Comparison of Everolimus-Eluting vs. Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention　― 3-Year Clinical Outcomes of the EXCELLENT Randomized Trial ―

Published:2018-05-25 Issue:6 Volume:82 Page:1566-1574
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Park Kyung Woo¹,Rhee Tae-Min¹,Kang Hyun-Jae¹,Koo Bon-Kwon¹,Gwon Hyeon-Cheol²,Yoon Jung-Han³,Lim Do-Sun⁴,Chae In-Ho⁵,Han Kyoo-Rok⁶,Ahn Taehoon⁷,Jeong Myung-Ho⁸,Jeon Dong-Woon⁹,Jang Yang-Soo¹⁰,Kim Hyo-Soo¹

Affiliation:

1. Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital

2. Sung-Kyun-Kwan University Samsung Medical Center

3. Yonsei University Wonju Severance Hospital

4. Korea University Anam Hospital

5. Seoul National University Bundang Hospital

6. Kangdong Sacred Heart Hospital

7. Gachon University Gil Medical Center

8. Chonnam National University Hospital

9. NHIC Ilsan Hospital

10. Yonsei University Severance Hospital

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/82/6/82_CJ-17-0677/_pdf

Reference28 articles.

1. 1. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315–1323.

2. 2. Stefanini GG, Holmes DR Jr. Drug-eluting coronary-artery stents. N Engl J Med 2013; 368: 254–265.

3. 3. Jensen LO, Tilsted HH, Thayssen P, Kaltoft A, Maeng M, Lassen JF, et al. Paclitaxel and sirolimus eluting stents versus bare metal stents: Long-term risk of stent thrombosis and other outcomes: From the Western Denmark Heart Registry. EuroIntervention 2010; 5: 898–905.

4. 4. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193–202.

5. 5. Stone GW, Rizvi A, Sudhir K, Newman W, Applegate RJ, Cannon LA, et al. Randomized comparison of everolimus- and paclitaxel-eluting stents: 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial. J Am Coll Cardiol 2011; 58: 19–25.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuous glucose monitoring in an end‐stage renal disease patient with diabetes receiving hemodialysis;Seminars in Dialysis;2021-08-10

2. Very Late Stent Thrombosis;Cardiovascular OCT Imaging;2019-10-12

3. Are All New-Generation Drug-Eluting Stents Equal?　― Long-Term Follow-up Is Necessary ―;Circulation Journal;2018-05-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3